Attarian S, Beloribi-Djefaflia S, Bernard R, Nguyen K, Cances C, Gavazza C
J Neurol. 2024; 271(9):5778-5803.
PMID: 38955828
DOI: 10.1007/s00415-024-12538-3.
Campbell A, Arjomand J, King O, Tawil R, Jagannathan S
J Neuromuscul Dis. 2023; 10(6):1031-1040.
PMID: 37899061
PMC: 10657687.
DOI: 10.3233/JND-221636.
Engquist E, Greco A, Joosten L, van Engelen B, Zammit P, Banerji C
Hum Mol Genet. 2023; 33(2):182-197.
PMID: 37856562
PMC: 10772042.
DOI: 10.1093/hmg/ddad175.
Butterfield R, Dunn D, Duval B, Moldt S, Weiss R
Genome Res. 2023; 33(9):1439-1454.
PMID: 37798116
PMC: 10620044.
DOI: 10.1101/gr.277871.123.
Zhuang J, Liu S, Chen X, Jiang Y, Chen C
Mol Cytogenet. 2023; 16(1):18.
PMID: 37533110
PMC: 10399047.
DOI: 10.1186/s13039-023-00651-3.
Influence of Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments.
Duranti E, Villa C
Int J Mol Sci. 2023; 24(11).
PMID: 37298453
PMC: 10253551.
DOI: 10.3390/ijms24119503.
WDR5 is required for DUX4 expression and its pathological effects in FSHD muscular dystrophy.
Mocciaro E, Giambruno R, Micheloni S, Cernilogar F, Andolfo A, Consonni C
Nucleic Acids Res. 2023; 51(10):5144-5161.
PMID: 37021550
PMC: 10250208.
DOI: 10.1093/nar/gkad230.
Deciphering D4Z4 CpG methylation gradients in fascioscapulohumeral muscular dystrophy using nanopore sequencing.
Butterfield R, Dunn D, Duval B, Moldt S, Weiss R
bioRxiv. 2023; .
PMID: 36824722
PMC: 9949141.
DOI: 10.1101/2023.02.17.528868.
Facioscapulohumeral muscular dystrophy: the road to targeted therapies.
Tihaya M, Mul K, Balog J, de Greef J, Tapscott S, Tawil R
Nat Rev Neurol. 2023; 19(2):91-108.
PMID: 36627512
PMC: 11578282.
DOI: 10.1038/s41582-022-00762-2.
Antagonism Between DUX4 and DUX4c Highlights a Pathomechanism Operating Through β-Catenin in Facioscapulohumeral Muscular Dystrophy.
Ganassi M, Figeac N, Reynaud M, Ortuste Quiroga H, Zammit P
Front Cell Dev Biol. 2022; 10:802573.
PMID: 36158201
PMC: 9490378.
DOI: 10.3389/fcell.2022.802573.
Intragenic L1 Insertion: One Possibility of Brain Disorder.
Son J, Do H, Han J
Life (Basel). 2022; 12(9).
PMID: 36143463
PMC: 9505610.
DOI: 10.3390/life12091425.
Dynamic spreading of chromatin-mediated gene silencing and reactivation between neighboring genes in single cells.
Lensch S, Herschl M, Ludwig C, Sinha J, Hinks M, Mukund A
Elife. 2022; 11.
PMID: 35678392
PMC: 9183234.
DOI: 10.7554/eLife.75115.
Epigenetic patterns in a complete human genome.
Gershman A, Sauria M, Guitart X, Vollger M, Hook P, Hoyt S
Science. 2022; 376(6588):eabj5089.
PMID: 35357915
PMC: 9170183.
DOI: 10.1126/science.abj5089.
Nucleolar-based repression is essential for embryonic two-cell stage exit.
Xie S, Leeke B, Whilding C, Wagner R, Garcia-Llagostera F, Low Y
Genes Dev. 2022; 36(5-6):331-347.
PMID: 35273077
PMC: 8973846.
DOI: 10.1101/gad.349172.121.
Cytosolic adaptation to mitochondria-induced proteostatic stress causes progressive muscle wasting.
Wang X, Middleton F, Tawil R, Chen X
iScience. 2022; 25(1):103715.
PMID: 35072007
PMC: 8762400.
DOI: 10.1016/j.isci.2021.103715.
DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy.
Mocciaro E, Runfola V, Ghezzi P, Pannese M, Gabellini D
Cells. 2021; 10(12).
PMID: 34943834
PMC: 8699294.
DOI: 10.3390/cells10123322.
A proteomics study identifying interactors of the FSHD2 gene product SMCHD1 reveals RUVBL1-dependent DUX4 repression.
Goossens R, Tihaya M, van den Heuvel A, Tabot-Ndip K, Willemsen I, Tapscott S
Sci Rep. 2021; 11(1):23642.
PMID: 34880314
PMC: 8654949.
DOI: 10.1038/s41598-021-03030-3.
A multi-objective genetic algorithm to find active modules in multiplex biological networks.
Novoa-Del-Toro E, Mezura-Montes E, Vignes M, Terezol M, Magdinier F, Tichit L
PLoS Comput Biol. 2021; 17(8):e1009263.
PMID: 34460810
PMC: 8452006.
DOI: 10.1371/journal.pcbi.1009263.
Promising Perspective to Facioscapulohumeral Muscular Dystrophy Treatment: Nutraceuticals and Phytochemicals.
Hangul C, Karauzum S, Akkol E, Demir-Dora D, Cetin Z, Saygili E
Curr Neuropharmacol. 2021; 19(12):2276-2295.
PMID: 34315378
PMC: 9185762.
DOI: 10.2174/1570159X19666210726151924.
Redox Homeostasis in Muscular Dystrophies.
Mosca N, Petrillo S, Bortolani S, Monforte M, Ricci E, Piemonte F
Cells. 2021; 10(6).
PMID: 34205993
PMC: 8229249.
DOI: 10.3390/cells10061364.